Chorioamnionitis: Is a major player in the development of bronchopulmonary dysplasia?
Chang Won Choi
Clin Exp Pediatr. 2017;60(7):203-207.   Published online 2017 Jul 31     DOI: https://doi.org/10.3345/kjp.2017.60.7.203
Citations to this article as recorded by Crossref logo
The Relationship between Histological Chorioamnionitis and Bronchopulmonary Dysplasia in Low-Birth Weight Infants: Changes of C-Reactive Protein in Bronchopulmonary Dysplasia
Kyungju Kim, Ji Won Jang, Ji Hyeon Moon, Jeonghee Shin, Eun Hee Lee, Byung Min Choi, Young Sook Hong, Min Jeong Oh
Perinatology.2019; 30(1): 8.     CrossRef
Small for gestational age very preterm infants present a higher risk of developing bronchopulmonary dysplasia
G. Rocha, F. Flor de Lima, A. Paula Machado, H. Guimarães, E. Proença, C. Carvalho, L.G. Martins, T. Martins, A. Freitas, C.P. Dias, A. Silva, A. Barroso, I. Diogo, G. Cassiano, H. Ramos, M.M. Abrantes, P. Costa, A. Salazar, F. Vieira, D. Fontes, R. Barro
Journal of Neonatal-Perinatal Medicine.2019; : 1.     CrossRef
CTGF: A potential therapeutic target for Bronchopulmonary dysplasia
Xinbao Wang, Hong Cui, Shu Wu
European Journal of Pharmacology.2019; 860: 172588.     CrossRef
Bronchopulmonary dysplasia: how can we improve its outcomes?
Tae-Jung Sung
Korean Journal of Pediatrics.2019; 62(10): 367.     CrossRef
Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia
Ettore Lignelli, Francesco Palumbo, Despoina Myti, Rory E. Morty
American Journal of Physiology-Lung Cellular and M.2019; 317(6): L832.     CrossRef